| Patient No | Age/sex | Handedness | Epilepsy onset (y) | Seizure types and frequency (per month) | Post-op outcome (ILAE class.) | Duration of follow-up (months) | MRI and pathological diagnosis | Clinical and EEG | RHV (cm3) | LHV (cm3) | TIV (cl) | HVR (%) | AEDs (mg/day) | Language dominance |
| 1 | 25/F | Right | 17 | CPS 8 SGTC 0.5 | 1 | 42 | Left HS | Left TLE | 2.729 | 1.351 | 168.5 | 50 | TPR 150 LTG 200 | Left |
| 2 | 37/M | Left | 1 | SPS 12 CPS 4 | 2 | 40 | Left HS | Left TLE | 3.3 | 1.88 | 175 | 57 | VPA 800 CBZ 800 LVT 2000 | Left |
| 3 | 33/M | Right | 1 | SPS 4 CPS 4 | 1 | 36 | Left HS | Left TLE | 2.83 | 2.02 | NM | 71 | PMD 500 CBZ 1200 CLB 10 TPR 175 | Left |
| 4 | 37/F | Right | 18 | CPS 10 | 1 | 24 | Left HS | Left TLE | 2.912 | 1.602 | 143.5 | 55 | CBZ 1200 GBP 2700 | Left |
| 5 | 28/M | Right | 3 | CPS 1 | 1 | 36 | Left HS | Left TLE | 3.077 | 1.417 | 171.2 | 46 | LVT 3000 | Left |
| LTG 600 | ||||||||||||||
| 6 | 31/M | Right | 10 | CPS 50 SGTC 3 | 1 | NA | Left MTL DNET | Left TLE | 3.731 | 3.797 | 187.2 | 98 | CBZ 1200 CLN 1.5 LTG 100 | Left |
| 7 | 37/F | Right | 1 | SPS 12 CPS 8 SGTC 1 | 3 | 30 | Left HS, left fusiform gyrus ganglioglioma | Left TLE | 2.8 | 2.385 | 134.8 | 85 | CBZ 1000 CLB 10 | Left |
| 8 | 47/M | Right | 13 | CPS 1 | 2 | 36 | Right HS | Right TLE | 1.038 | 2.769 | 145.9 | 37 | LVT 500 PHT 300 CBZ 800 | Left |
| 9 | 44/F | Right | 14 | CPS 4 | 1 | 30 | Right HS | Right TLE | 2.606 | 3.034 | 154.9 | 86 | LVT 750 PHT 400 CLB 10 | Left |
| 10 | 36/M | Left | 15 | SPS 6 CPS 6 SGTC 3 | 1 | 24 | Right MTL glioma | Right TLE | 3.118 | 2.774 | 152.3 | 89 | CBZ 1600 CLB 20 LTG 400 | Right |
| 11 | 46/F | Right | 8 | CPS 5 | 1 | 24 | Right HS | Right TLE | 1.756 | 2.695 | 147 | 65 | TPR 600 PMD 1000 OXC 2400 | Left |
| 12 | 32/F | Right | 19 | CPS 2 | 4 | 36 | Right HS | Right TLE | 2.299 | 2.562 | 139.5 | 90 | CBZ 1600 LVT 1000 | Left |
| 13 | 29/M | Right | 9 | CPS 30 SGTC 4 | 3 | 36 | Right HS | Right TLE | 2.273 | 2.978 | 162.9 | 76 | VPA 2400 | Left |
| 14 | 22/M | Left | 18 | CPS 3 SGTC 0.33 | 1 | 32 | Right MTL DNET | Right TLE | 2.493 | 2.554 | 168.4 | 98 | VPA 2000 GBP 600 | Left |
| 15 | 41/F | Right | 14 | CPS 4 | 1 | NA | Right HS | Right TLE | 1.628 | 2.302 | 150.8 | 71 | TGB 15 | Left |
AED, antiepileptic drug; CBZ, carbamazepine; CLB, clobazam; CLN, clonazepam; CPS, complex partial seizure; DNET, dysembryoplastic neuroepithelial tumour; EEG, electroencephalogram; GBP, gabapentin; HS, hippocampal sclerosis; HVR, hippocampal volume ratio of affected to unaffected side; LHV, left hippocampal volume; LTG, lamotrigine; LVT, levetiracetam; MTL, medial temporal lobe; NA, not available; NM, not measured; OXC, oxcarbazepine; PHT, phenytoin; PMD, primidone; RHV, right hippocampal volume; SGTC, secondary generalised tonic–clonic seizure; SPS, simple partial seizure; TGB, tiagabine; TIV, total intracranial volume; TLE, temporal lobe epilepsy; TPR, topiramate; VPA, sodium valproate.